3,4-Methylenedioxyphentermine
3,4-Methylenedioxyphentermine is a psychoactive drug of the amphetamine family. MDPH was first synthesized by Alexander Shulgin. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDPH.
Use and effects
In his book PiHKAL (Phenethylamines i Have Known And Loved), the dose range is listed as 160–240 mg, and the duration as 3 to 5hours. MDPH's effects are very similar to those of MDA: they both are smooth and "stoning," and do not cause any visuals. They also alter dreams and dream patterns. But it is said to have none of the magic of MDMA. Shulgin describes MDPH as a promoter; it promotes the effects of other drugs, similarly to 2C-D.
Chemistry
Synthesis
The chemical synthesis of MDPH has been described.
Analogues
The N-methyl derivative, 3,4-methylenedioxy-N-methylphentermine, has been described by Shulgin as lacking MDMA-like effects. Accordingly, MDMPH, as well as MDPH, were found to be inactive as serotonin releasing agents in vitro.
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.